News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Why M&A Hungry Sanofi Could be Gearing Up to Buy Sarepta
May 1, 2017
·
2 min read
Genetown
Here’s Why Sarepta May Be The Rarest Of Finds: A ‘Value’ Biotech Stock
May 1, 2017
·
1 min read
Business
M&A Speculation Begins as Sarepta CEO Puts in His Notice
April 28, 2017
·
2 min read
Business
Sarepta CEO Gives CMO Role to Former Amgen-Regeneron Alum
April 4, 2017
·
3 min read
Deals
Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million
February 21, 2017
·
2 min read
FDA
Sarepta Under Pressure As Marathon Pharma Emflaza’s Wins FDA Approval for DMD
February 10, 2017
·
3 min read
Genetown
JPM17: Sarepta’s New Numbers Impress Investors, Stock Gained $300 Million Overnight
January 11, 2017
·
2 min read
Deals
With Donald Trump as President, Here’s What Biotech M&A and Drug Pricing Could Look Like (and Renewed Takeover Interest for Tesaro and Sarepta
November 11, 2016
·
3 min read
Job Trends
Sarepta’s New Facility to Open in Early 2017, Plans to Hire 45 New Staffers
November 4, 2016
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Genetown
Sarepta Therapeutics to Announce First Quarter 2021 Financial Results and Recent Corporate Developments on May 5, 2021
April 28, 2021
·
1 min read
Deals
Sarepta Recommends Stockholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
April 26, 2021
·
3 min read
Genetown
Sarepta Therapeutics Announces Fourth Year of Route 79, The Duchenne Scholarship Program
March 23, 2021
·
3 min read
Genetown
Sarepta Therapeutics’ Investigational Gene Therapy SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Expression and Functional Improvements 2 Years After Administration
March 18, 2021
·
9 min read
Genetown
Sarepta Therapeutics to Present Results from its Gene Therapy and RNA Platforms at the 2021 Annual MDA Clinical and Scientific Conference
March 15, 2021
·
3 min read
Business
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments
March 1, 2021
·
41 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Feb 27, 2021
February 26, 2021
·
2 min read
FDA
FDA Approves Targeted Treatment for Rare Duchenne Muscular Dystrophy Mutation - Feb 25, 2021
February 25, 2021
·
4 min read
FDA
Sarepta Therapeutics Announces FDA Approval of AMONDYS 45™ (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45
February 25, 2021
·
10 min read
Genetown
Sarepta Therapeutics to Present at Upcoming Investor Conferences - Feb 24, 2021
February 24, 2021
·
1 min read
